JVIR supplement to review thermal ablation usage in treating cancer

August JVIR supplement offers review of outcomes, state-of-the-art devices and uses to medically kill cancer

The unprecedented growth and promise of using thermal ablation to target and kill cancer is the subject of the Journal of Vascular and Interventional Radiology's August supplement, "Thermal Ablation 2010: At the Crossroads of Past Success, Current Goals and Future Technology."

"The Journal of Vascular and Interventional Radiology supplement sheds light on the development of multiple medical techniques and devices for cancer tumor ablation," said Daniel B. Brown, M.D., guest editor. "For all its richness of information, the JVIR supplement should be considered a snapshot of the state of the art," added Brown, an interventional radiologist and chief of interventional radiology and interventional oncology at Thomas Jefferson University Hospital in Philadelphia, Pa. The supplement articles provide a current overview of the types of ablation devices that are commonly used and are now expanding in clinical practice and review the current status of ablation outcomes in different organ systems.

"As interventional oncology continues to grow over the next few years, additional advances will be made within existing and novel treatments, including liquid nitrogen-based cryotherapy, newer microwave devices, magnetic resonance-guided focused ultrasound and other technologies," said Brown.

"Interventional radiologists and other practitioners interested in tumor ablation currently face a number of challenging questions: What patients are best served by ablation? What results can be anticipated? Can ablation be combined with other types of tumor therapy to improve outcomes?" said JVIR editor Albert A. Nemcek Jr., M.D., FSIR. "This supplement helps answer those questions," said Nemcek, an interventional radiologist and professor of radiology and surgery at Northwestern Memorial Hospital in Chicago, Ill.

The following articles are included in "Thermal Ablation 2010: At the Crossroads of Past Success, Current Goals and Future Technology."

  • "Radiofrequency Ablation: Mechanism of Action and Devices"
  • "Cryoablation: Mechanism of Action and Devices"
  • "Microwave Tumor Ablation: Mechanism of Action, Clinical Results and Devices"
  • "Percutaneous Ablation of Hepatocellular Carcinoma: Current Status"
  • "Ablation of Liver Metastases: Current Status"
  • "Ablation of Pulmonary Malignancy: Current Status"
  • "Thermal Ablation of Renal Cell Carcinoma: Triage, Treatment and Follow-up"
  • "Ablation of Skeletal Metastases: Current Status"
  • "Enhancing Ablation: Synergies With Regional and Systemic Therapies"
  • "Navigation Systems for Ablation"

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Blood cancer drug could help improve the efficiency of radiotherapy in meningiomas